This inventor holds 3 USPTO granted patents and 6 published patent applications and 2 EPO patents. Top assignee: Arrowhead Pharmaceuticals, Inc.. Active years: 2018-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Madison, WI (US) (2018 - 2020)
- Pasadena, CA (US) (2022)
Company Filing History:
Years Active: 2018-2022
Title: The Innovative Contributions of Stacey Melquist
Introduction
Stacey Melquist is a prominent inventor based in Madison, Wisconsin. She has made significant contributions to the field of biotechnology, particularly in the development of RNA interference (RNAi) agents. With a total of three patents to her name, her work focuses on innovative methods for inhibiting gene expression related to various diseases.
Latest Patents
Stacey Melquist's latest patents include groundbreaking compositions and methods for inhibiting the expression of the Asialoglycoprotein receptor 1 (ASGR1) gene. These patents describe RNAi agents, such as double-stranded RNAi agents, and RNAi agent-targeting ligand conjugates that can effectively inhibit ASGR1 gene expression. The pharmaceutical compositions developed can be utilized in treating cardiometabolic diseases associated with elevated cholesterol and triglyceride levels. Additionally, she has patented RNAi agents and conjugates aimed at inhibiting the expression of the LPA (apo(a)) gene. These agents are designed for delivery to liver cells, providing a method for treating cardiovascular diseases.
Career Highlights
Stacey Melquist is currently employed at Arrowhead Pharmaceuticals, Inc., where she continues to advance her research in RNAi technology. Her work has the potential to revolutionize treatment options for patients suffering from various metabolic and cardiovascular conditions.
Collaborations
Stacey collaborates with talented colleagues, including Tao Pei and Zhen Li, who contribute to her innovative research efforts.
Conclusion
Stacey Melquist's contributions to biotechnology through her patents and research at Arrowhead Pharmaceuticals highlight her role as a leading inventor in the field. Her work on RNAi agents is paving the way for new therapeutic approaches to treat significant health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile